Diasol 1002225-75200
by Diasol Inc
Diasol 1002225-75200 (ACD5-ACG14) is a haemodialysis concentrate (FDA Class II; FDA product code KPO, Dialysate Concentrate For Hemodialysis (Liquid Or Powder)) made by Diasol Inc, cleared under FDA 510(k) K851431 on 12 Jun 1985 and listed in FDA GUDID since 25 Jan 2017 (UDI-DI B467100222575200), active as of 23 Oct 2026. 8 FDA recalls are linked to it.
Active
Valid until
No expiry
FDA recalls
7 ongoingDocuments
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | NumberB467100222575200 | Date25 Jan 2017 | StatusListed |
| United States | FDA 510(k)SESE | NumberK851431 | Date12 Jun 1985 | StatusActive |
Official records
- FDA 510(k) database K851431
From the FDA record
- Device description
- Diasol Liquid Acid Concentrate for Bicarbonate Dialysis
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K851431 decided 12 Jun 1985 Active
- FDA GUDID UDI-DI B467100222575200 listed 25 Jan 2017 Listed
Recalls
-
- Ongoing Z-0991-2026
- Ongoing Z-0992-2026
- Ongoing Z-0989-2026
- Ongoing Z-0990-2026
- Ongoing Z-0987-2026
- Ongoing Z-0988-2026
Safety and efficacy of dialysis acid concentrate cannot be assured
-
- Ongoing Z-0207-2025
Due to labeling issue. The box label is different that the gallon label in that gallon label shows a lower Calcium concentration than the box label.
-
- Terminated Z-2402-2020
Incorrect labeling of dialysate concentration for hemodialysis.
Timeline
- Cleared FDA 510(k) K851431
- Listed FDA GUDID B467100222575200
- Recall initiated FDA recalls Z-2402-2020
- Recall initiated FDA recalls Z-0207-2025
- Recall initiated FDA recalls Z-0991-2026
- Recall initiated FDA recalls Z-0992-2026
- Recall initiated FDA recalls Z-0989-2026
- Recall initiated FDA recalls Z-0990-2026
- Recall initiated FDA recalls Z-0987-2026
- Recall initiated FDA recalls Z-0988-2026
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Diasol
- Generic name
- Haemodialysis concentrate
- Model / Ref / Catalog
- 1002225-75200, ACD5-ACG14
- Primary DI / UDI-DI
- B467100222575200
- 510(k) Number
- FDA product code
- KPO
- GMDN term
- Haemodialysis concentrate
- Device class
- Class II
- Regulation number
- 876.5820
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code KPO (Dialysate Concentrate For Hemodialysis (Liquid Or Powder)).
- FRESENIUS DIALYSATE ACID CONCENTRATE by Fresenius Usa, Inc.
- NXSTAGE PUREFLOW SOLUTION by NxStage Medical, Inc.
- Isopure Dry Acid Dissolution System by Isopure, Corp.
- SODIUM BICARBONATE POWDER/BICARBONATE HEMODIALYSIS by American Healthcare, Inc.
- BICARBONATE CONCENTRATE POWDER by Haemolyte, Inc.
- DIALYSATE CONCENTRATE FOR HEMODIALYSIS by Cobe Laboratories, Inc.
- BIASOL LIQUID CONCENTRATES, ADD'L ACID CONCENTRATE by Baxter Healthcare Corp
- HEMODIALYSATE by EDLAW PHARMACEUTICALS, INC.
- HEMODIALYSIS CONCENTRATE SOLUTION by Mid Atlantic Nephrology Center
- DRYALYSATE CONCENTRATE by Advanced Renal Technologies, Inc.